Clinical Trial Update: A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating idebenone for Rapid Eye Movement Sleep Behavior Disorder evolving into synucleinopathies, with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rapid Eye Movement Sleep Behavior Disorder
• Synucleinopathy

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Ruijin Hospital | Conditions: Rapid Eye Movement Sleep Behavior Disorder, Synucleinopathy | Phase 2 | Status: ACTIVE_NOT_RECRUITING